test

Alyssa Romano

@Velan Capital Investment Management Lp

Latest period2024 - Q3ReportedManaged Assets$106.939MTotal holdings18
Assets growth rate-38.73%Assets growth rate (2-Q avg)-29.73%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Velan Capital Investment Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 18 positions.

Assets under management

The assets under management (AUM) of Velan Capital Investment Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 106.939M in assets, with a quarterly growth rate of -38.73% and a 2-quarter average growth rate of -29.73%. The portfolio is managed by Alyssa Romano, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
JSPRJasper Therapeutics Inc
Recent Activity
Decreased -2.58%
25.23%
$26.97M
1.434M shares@ $18.82 avg price
PRAXPraxis Precision Medicines I
Recent Activity
18.87%
$20.177M
350,666 shares@ $57.55 avg price
XBISpdr Ser Tr
Recent Activity
New Position
13.86%
$14.82M↑ Call
150,000 shares@ $98.8 avg price
HRTXHeron Therapeutics Inc
Recent Activity
13.01%
$13.904M
6.987M shares@ $2.0 avg price
TRMLTourmaline Bio Inc
Recent Activity
Increased 3.8%
7.97%
$8.515M
331,190 shares@ $25.72 avg price
RZLTRezolute Inc
Recent Activity
3.63%
$3.88M
800,000 shares@ $4.85 avg price
LQDALiquidia Corporation
Recent Activity
New Position
2.81%
$3M
300,000 shares@ $10.0 avg price
CNTXContext Therapeutics Inc
Recent Activity
2.37%
$2.529M
1.29M shares@ $1.96 avg price
NSPRInspiremd Inc
Recent Activity
2.27%
$2.423M
904,029 shares@ $2.69 avg price
SCPHScpharmaceuticals Inc
Recent Activity
New Position
2.21%
$2.361M
517,668 shares@ $4.56 avg price